Business Context and Reporting Period
This Form 8-K, dated January 27, 2021, reports on Schweitzer-Mauduit International, Inc. (SWM). The filing discloses the entry into a material definitive agreement to acquire Scapa Group plc (Scapa), a UK-based specialty paper manufacturer listed on the London Stock Exchange's AIM market. The transaction is structured as a recommended cash offer via a scheme of arrangement.
Key Financial Metrics and Transaction Terms
- Offer Price: £2.10 in cash per Scapa ordinary share.
- Total Enterprise Value: Approximately £402.9 million (approximately $551.9 million based on an exchange rate of US$1.37:£1).
- Financing: SWM entered into a $1,045.5 million backstop credit agreement with JPMorgan Chase Bank, N.A. to fund the cash consideration and transaction expenses.
- Shareholder Support:
- Irrevocable undertakings from Scapa directors representing 0.66% of issued share capital.
- Non-binding letters of intent from institutional shareholders representing 15.99% of issued share capital.
Material Changes and Conditions
The filing details the conditions precedent required for the acquisition to close, including:
- Approval by a majority in number of Scapa shareholders representing at least 75% in value of shares voted.
- Sanction by the High Court of Justice in England and Wales.
- Receipt of necessary merger control and regulatory approvals.
- Effectiveness of the scheme no later than the "Long Stop Date" of July 27, 2021.
The company intends to replace the temporary backstop facility with an amended version of its existing $700 million credit agreement, adding a new Term Loan B facility.
Outlook, Risks, and Contingencies
Expected Timeline: Subject to conditions, the scheme is expected to become effective during the second quarter of 2021.
Risks and Contingencies:
- The offer is subject to a "certain funds" provision until the Long Stop Date or earlier termination.
- The Co-operation Agreement may be terminated if conditions become incapable of satisfaction, if Scapa directors withdraw their recommendation, or if a competing proposal is recommended.
- Regulatory approval is not guaranteed.
Financial Data: This filing does not provide SWM's current revenue, profit, cash flow, or margin data. It focuses exclusively on the transaction structure and financing.
Investor Verification Checklist
- Verify the final exchange rate impact on the total transaction cost at closing.
- Monitor the status of UK regulatory approvals and the High Court sanction.
- Confirm the final terms of the amended credit agreement replacing the backstop facility.
- Review the full text of the Rule 2.7 Announcement and Scheme Document for detailed voting procedures.
- Assess the integration risks and synergies associated with acquiring a UK-based specialty paper manufacturer.